Universe Pharmaceuticals Stock Performance
| UPC Stock | USD 4.39 0.87 24.72% |
Universe Pharmaceuticals holds a performance score of 8 on a scale of zero to a hundred. The entity has a beta of -2.46, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Universe Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Universe Pharmaceuticals is expected to outperform it. Use Universe Pharmaceuticals maximum drawdown, as well as the relationship between the accumulation distribution and day typical price , to analyze future returns on Universe Pharmaceuticals.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Universe Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Universe Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:40 | Last Split Date 2025-03-24 |
1 | SABBY MANAGEMENT, LLC Acquires Significant Stake in Universe Pha - GuruFocus.com | 01/03/2025 |
2 | Universe Pharmaceuticals stock hits 52-week low at 0.48 amid steep decline - MSN | 01/29/2025 |
3 | Baby teething sticks recalled over potential choking hazard | 02/03/2025 |
4 | Universe Pharmaceuticals proposes revised share consolidation - Investing.com | 02/11/2025 |
5 | Acquisition by White John V of 1222 shares of Universe Pharmaceuticals subject to Rule 16b-3 | 02/13/2025 |
6 | Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report | 02/25/2025 |
7 | Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN | 02/27/2025 |
8 | Universe Pharmaceuticals stock plunges to 52-week low of 0.1 - Investing.com | 03/14/2025 |
| Begin Period Cash Flow | 5.7 M |
Universe |
Universe Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 63.00 in Universe Pharmaceuticals on December 24, 2024 and sell it today you would earn a total of 376.00 from holding Universe Pharmaceuticals or generate 596.83% return on investment over 90 days. Universe Pharmaceuticals is generating 14.1917% of daily returns assuming volatility of 128.7818% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Universe, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Universe Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Universe Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Universe Pharmaceuticals, and traders can use it to determine the average amount a Universe Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1102
| Best Portfolio | Best Equity | UPC | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 128.78 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.96 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Universe Pharmaceuticals is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Universe Pharmaceuticals by adding it to a well-diversified portfolio.
Universe Pharmaceuticals Fundamentals Growth
Universe Stock prices reflect investors' perceptions of the future prospects and financial health of Universe Pharmaceuticals, and Universe Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Universe Stock performance.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.0565 | ||||
| Profit Margin | (0.69) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | (3.57 M) | ||||
| Shares Outstanding | 380.63 K | ||||
| Price To Earning | 3.02 X | ||||
| Price To Book | 0.05 X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 32.31 M | ||||
| Gross Profit | 7.56 M | ||||
| EBITDA | (3.22 M) | ||||
| Net Income | (6.16 M) | ||||
| Cash And Equivalents | 28.58 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 5.48 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.06 X | ||||
| Book Value Per Share | 110.03 X | ||||
| Cash Flow From Operations | 1.12 M | ||||
| Earnings Per Share | (3,054) X | ||||
| Market Capitalization | 33.53 K | ||||
| Total Asset | 53.29 M | ||||
| Retained Earnings | 10.16 M | ||||
| Working Capital | 23.06 M | ||||
About Universe Pharmaceuticals Performance
By analyzing Universe Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Universe Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Universe Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Universe Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 63.81 | 78.01 | |
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.10) | (0.10) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.18) | (0.17) |
Things to note about Universe Pharmaceuticals performance evaluation
Checking the ongoing alerts about Universe Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Universe Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Universe Pharmaceuticals is way too risky over 90 days horizon | |
| Universe Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 7.56 M. | |
| Latest headline from news.google.com: Universe Pharmaceuticals stock plunges to 52-week low of 0.1 - Investing.com |
- Analyzing Universe Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Universe Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Universe Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Universe Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Universe Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Universe Pharmaceuticals' stock. These opinions can provide insight into Universe Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |